Skip to content

Drug interactions

Pomalidomide + Propafenone

Severity: Minor

Pomalidomide and Propafenone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pomalidomide is a P-glycoprotein substrate and propafenone has weak P-gp inhibitory activity. Any rise in pomalidomide exposure is expected to be small and is not known to be clinically significant.

What this interaction means in plain words

Pomalidomide and Propafenone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Pomalidomide belongs to Miscellaneous; Propafenone belongs to Cardiovascular.

Evidence level: Low

Why it happens

Possible weak P-glycoprotein inhibition by propafenone increasing pomalidomide exposure.

What to do

No dose change is usually needed. Monitor for pomalidomide adverse effects such as neutropenia.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pomalidomide and Propafenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Pomalidomide with Propafenone?

MediHelp rates the interaction as minor. Pomalidomide and Propafenone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Pomalidomide is a P-glycoprotein substrate and propafenone has weak P-gp inhibitory activity. Any rise in pomalidomide exposure is expected to be small and is not known to be clinically significant.

How serious is the interaction between Pomalidomide and Propafenone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually needed. Monitor for pomalidomide adverse effects such as neutropenia.

What other medicines interact with Propafenone?

MediHelp also lists interactions of Propafenone with, for example, Dofetilide, Dronedarone, Nilotinib. The full list is on the Propafenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in